Cell & Gene Therapy

Our multi-disciplinary team can help assess healthcare ecosystem readiness, disease burden perception, patient voice and optimal contracting strategies, to maximize patient access and minimize perceptions risks associated with ground-breaking therapies.

Case Studies

Developed a market map to inform a mid-size GTx manufacturer’s commercial strategy and launch planning

Developed comprehensive approach to navigate international reimbursement for a GTx while managing channel-specific pricing considerations

Developed a launch excellence plan, based on local market inputs for a global pharmaceutical company

Developed a comprehensive understanding of referral flows for a Cell Therapy in development for Type 1 Diabetes to inform strategic commercial engagement planning at a mid-sized pharmaceutical company

Defined the key requirements for novel GTx entry and regional access to inform regional access strategies and planned activities and further organizational alignment initiatives

Developed drivers and potential barriers of Hematologist GTx adoption to understand the impacts on patient adoption and inform strategic commercialization planning for a mid-sized biotech